BRCA2 and ovarian carcinoma: Familial risk is associated with mutations in BRCA1 and BRCA2 genes, which conferred respectively 59% and 16.5% risk of developing ovarian cancer by the age of 70 in the Epidemiological Study of BRCA1 and BRCA2 mutation carriers (EMBRACE) in the UK [17].